Compounds > 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
Page last updated: 2024-09-03

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and verapamil

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with verapamil in 1 studies

Compound Research Comparison

Studies
(4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide)		Trials
(4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide)		Recent Studies (post-2010)
(4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide)		Studies
(verapamil)		Trials
(verapamil)		Recent Studies (post-2010) (verapamil)
6201417,6211,5272,067

Protein Interaction Comparison

ProteinTaxonomy4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide (IC50)verapamil (IC50)
Solute carrier family 22 member 1 Homo sapiens (human)6.8
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)0.2
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.297
ATP-dependent translocase ABCB1Mus musculus (house mouse)2
ATP-dependent translocase ABCB1Homo sapiens (human)2.2346
Cytochrome P450 3A4Homo sapiens (human)3.8008
Alpha-2A adrenergic receptorHomo sapiens (human)0.579
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)3.02
ATP-dependent translocase ABCB1Mus musculus (house mouse)10
Catechol O-methyltransferaseHomo sapiens (human)0.2
Potassium voltage-gated channel subfamily A member 3Homo sapiens (human)8
Histamine H2 receptorHomo sapiens (human)2.59
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.442
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.297
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)3.02
Sodium-dependent serotonin transporterHomo sapiens (human)0.24
Multidrug resistance-associated protein 1 Homo sapiens (human)5.598
D(3) dopamine receptorHomo sapiens (human)0.186
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.165
5-hydroxytryptamine receptor 7Cavia porcellus (domestic guinea pig)6.8
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)0.2
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.3945
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)0.2
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)0.175
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)1.1934

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harada, N; Mawatari, K; Nakamura, A; Nakano, M; Nakaya, Y; Takahashi, A; Tsutsumi, K1

Other Studies

1 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and verapamil

ArticleYear
NO-1886, a lipoprotein lipase activator, attenuates vascular smooth muscle contraction in rat aorta.
    European journal of pharmacology, 2007, Jan-12, Volume: 554, Issue:2-3

    Topics: Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Benzamides; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Activators; Flavonoids; Hypolipidemic Agents; In Vitro Techniques; Lipoprotein Lipase; Male; Muscle Contraction; Muscle, Smooth, Vascular; Organophosphorus Compounds; Phenylephrine; Potassium Chloride; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Staurosporine; Vasoconstriction; Vasodilation; Verapamil

2007